Romania kicks off vaccination with AstraZeneca jab

0 526
Over 142,000 Romanians ( 60,671 women and 72,429 men) have scheduled so far to take the AstraZeneca jab.
Overall there are 1.5 million appointments for vaccination, according to the Vaccine Coordination Committee.

“There are 673,593 appointments and people scheduled for the first dose, plus 923,247 for the rappel dose (673,593 people with the first dose and 249,654 only with the rappel),” the Committee reports.

More than 100,000 people had made an appointment to take the AstraZeneca vaccine within just 24 hours at the end of last week.

The scheduling for the AstraZeneca started on February 10 and is carried out in a 20-day session during February 15-March 6 for the people scheduled for vaccination in the second category (meaning the chronically ill and workers in the key sectors who are younger than 60). Subsequently, new slots of AstraZeneca vaccines will be allotted every day, till April 11.

180 new vaccination centres will be opened countrywide for the vaccination with the AstraZeneca jab, with 22 of them in Bucharest.

The vaccine produced by AstraZeneca is the third jab against COVID-19 authorized by the European Commission, after Pfizer BioNTech and Moderna.

The vaccination appointments can be made through the vaccination online platform, through the family doctor or directly at the call center by calling 021.414.44.25.

The anti-Covid jab developed by Oxford University and Astra Zeneca will be also tested on children in a new clinical trial in UK, The Guardian reported. Researchers will use 300 volunteers to establish of the serum, also known as ChAdOx1 nCoV-19, produces a strong immune response in children aged 6 yo 17.

So far, none of the three authorized vaccines -Pfizer, Moderna and AstraZeneca- are recommended to children.

COVID-19 Vaccine AstraZeneca was co-invented by the University of Oxford and its spin-out company, Vaccitech. It uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein. After vaccination, the surface spike protein is produced, priming the immune system to attack the SARS-CoV-2 virus if it later infects the body.

The AstraZeneca COVID-19 vaccine is currently granted a conditional marketing authorisation or emergency use in close to 50 countries, spanning four continents including in the EU, a number of Latin American countries, India, Morocco and the UK.

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries.
The small-scale study showed the vaccine works slightly better against older, more established versions of the virus. For those with the older strain, the vaccine was effective in 84% of symptomatic cases and 81% of all cases.

COVID-19 Vaccine AstraZeneca is given as two injections into the arm, the second between 4 to 12 weeks after the first. The most common side effects with COVID-19 Vaccine AstraZeneca were usually mild or moderate and got better within a few days after vaccination. The most common side effects are pain and tenderness at the injection site, headache, tiredness, muscle pain, general feeling of being unwell, chills, fever, joint pain and nausea.

- Advertisement -

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More